Loading...
Lobe Sciences Ltd.
LOBE.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.04
CA$0.00(0.00%)
Lobe Sciences Ltd. (LOBE.CN) Financial Performance & Income Statement Overview
Review Lobe Sciences Ltd. (LOBE.CN) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-83.80%
↓ 83.80%
Operating Income Growth
37.009%
↑ 37.009%
Net Income Growth
6.09%
↑ 6.09%
Operating Cash Flow Growth
73.10%
↑ 73.10%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
166.66%
↑ 166.66%
ROIC
83.71%
↑ 83.71%
Lobe Sciences Ltd. (LOBE.CN) Income Statement & Financial Overview
Review Lobe Sciences Ltd. (LOBE.CN) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $24286.00 | $25550.00 | $237772.00 | $29537.00 |
| Short Term Investments | $0.00 | $0.00 | $0.00 | $11455.00 |
| Cash & Short Term Investments | $24286.00 | $25550.00 | $237772.00 | $29537.00 |
| Net Receivables | $4815.00 | $14902.00 | $9343.00 | $9012.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $15358.00 |
| Other Current Assets | $20000.00 | $20000.00 | $11455.00 | $11455.00 |
| Total Current Assets | $49101.00 | $60452.00 | $258570.00 | $65362.00 |
| Property Plant & Equipment (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $1.90M |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $1.90M |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Assets | $0.00 | $0.00 | $0.00 | $1.90M |
| Total Assets | $49101.00 | $60452.00 | $258570.00 | $1.96M |
| Account Payables | $849480.00 | $801813.00 | $784321.00 | $654601.00 |
| Short Term Debt | $641374.00 | $641374.00 | $641374.00 | $280047.00 |
| Tax Payables | $0.00 | $238000.00 | $238000.00 | $205000.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $787977.00 | $578006.00 | $603724.00 | $0.00 |
| Total Current Liabilities | $2.28M | $2.26M | $2.27M | $1.14M |
| Long Term Debt | $1.51M | $1.26M | $1.11M | $1.93M |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $1.51M | $1.26M | $1.11M | $1.93M |
| Capital Lease Obligations | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $3.79M | $3.52M | $3.37M | $3.07M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $31.05M | $30.86M | $30.61M | $29.91M |
| Retained Earnings | -$41.61M | -$40.90M | -$40.10M | -$37.27M |
| Accumulated Other Comprehensive Income/Loss | $6.82M | $6.40M | $6.38M | $3.16M |
| Total Stockholders Equity | -$3.74M | -$3.46M | -$3.11M | -$1.11M |
| Total Equity | -$3.74M | -$3.46M | -$3.11M | -$1.11M |
| Total Liabilities & Stockholders Equity | $49101.00 | $60452.00 | $258570.00 | $1.96M |
| Total Investments | $0.00 | $0.00 | $0.00 | $11455.00 |
| Total Debt | $2.15M | $1.90M | $1.75M | $2.21M |
| Net Debt | $2.13M | $1.88M | $1.51M | $2.18M |
Lobe Sciences Ltd. (LOBE.CN) Balance Sheet Analysis
Lobe Sciences Ltd. (LOBE.CN) manages its money wisely, with plenty of 73.10% and 6.09% to cover its bills. The company’s long-term debts are N/A, balanced by steady 0.00%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a stable position, giving it room to invest, expand, or adapt. For investors, this paints a steady picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan